Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 270,026 | 265,772 | 120,863 | 129,418 | 158,617 |
| Marketable Securities | 206,693 | 189,404 | 66,712 | 65,485 | 78,468 |
| Receivables | 15,747 | 41,637 | 13,431 | 13,536 | 14,612 |
| Inventories | 17,103 | 18,594 | 19,981 | 25,418 | 24,170 |
| Other current assets | 0 | 0 | 228,406 | 230,676 | 223,089 |
| TOTAL | $516,867 | $521,453 | $454,264 | $472,439 | $506,037 |
| Non-Current Assets | |||||
| PPE Net | 15,300 | 17,103 | 19,275 | 20,738 | 22,678 |
| Investments And Advances | 67,280 | 71,357 | 25,701 | 19,485 | 0 |
| Other Non-Current Assets | 27,771 | 29,201 | 68,514 | 26,974 | 28,250 |
| TOTAL | $110,351 | $117,661 | $113,490 | $67,197 | $50,928 |
| Total Assets | $627,218 | $639,114 | $567,754 | $539,636 | $556,965 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,554 | 8,007 | 5,407 | 6,619 | 7,329 |
| Accrued Expenses | 29,608 | 15,684 | 29,783 | 30,810 | 24,207 |
| Other current liabilities | N/A | N/A | 25,633 | 22,214 | 17,984 |
| TOTAL | $56,802 | $42,203 | $108,308 | $107,965 | $98,024 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,019 | 12,972 | 41,995 | 43,209 | 43,410 |
| Other Non-Current Liabilities | 23,580 | 28,395 | 26,552 | 23,476 | 24,772 |
| TOTAL | $30,445 | $35,788 | $35,155 | $32,012 | $34,406 |
| Total Liabilities | $87,247 | $77,991 | $143,463 | $139,977 | $132,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 392,579 | 390,368 | 390,072 | 384,565 | 381,995 |
| Common Shares | 410 | 408 | 404 | 401 | 400 |
| Retained earnings | -1,160,237 | -1,133,479 | -1,260,547 | -1,279,830 | -1,245,143 |
| Other shareholders' equity | 716 | -978 | -1,959 | -944 | -2,395 |
| TOTAL | $539,971 | $561,123 | $424,291 | $399,659 | $424,535 |
| Total Liabilities And Equity | $627,218 | $639,114 | $567,754 | $539,636 | $556,965 |